Landmark Advancement in Flow Cytometry Technology With Potential To Transform Immunology and Genomics Research

Technology breakthrough has potential to transform wide range of disciplines from immunology and genomics research to cell-based therapeutics. BD (Becton, Dickinson and Company) (NYSE: BDX),...

The post Landmark Advancement in Flow Cytometry Technology With Potential To Transform Immunology and Genomics Research appeared first on SciTechDaily.

from SciTechDaily https://ift.tt/3FPWq3k